Heterogeneous oncologic outcomes according to surgical pathology in high-risk prostate cancer: implications for better risk stratification and preoperative prediction of oncologic outcomes-Reference-Cited by-同舟云学术

Heterogeneous oncologic outcomes according to surgical pathology in high-risk prostate cancer: implications for better risk stratification and preoperative prediction of oncologic outcomes

Published:2017-05-18 Issue:9 Volume:143 Page:1871-1878
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Choi Seung-Kwon,Shim Myungsun,Kim Myong,Park Myungchan,Lee Sangmi,Song Cheryn,Lee Hyung-Lae,Ahn Hanjong

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/article/10.1007/s00432-017-2437-z/fulltext.html

Reference29 articles.

1. Abdollah F et al (2015) Predicting pathological outcomes in patients undergoing robot-assisted radical prostatectomy for high-risk prostate cancer: a preoperative nomogram. BJU Int 116:703–712. doi: 10.1111/bju.12998

2. Alenda O et al (2011) Impact of the primary Gleason pattern on biochemical recurrence-free survival after radical prostatectomy: a single-center cohort of 1248 patients with Gleason 7 tumors. World J Urol 29:671–676. doi: 10.1007/s00345-010-0620-9

3. Bach C et al (2014) The status of surgery in the management of high-risk prostate cancer. Nat Rev Urology 11:342–351. doi: 10.1038/nrurol.2014.100

4. Boorjian SA et al (2011) Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer. Cancer 117:2883–2891. doi: 10.1002/cncr.25900

5. Briganti A et al (2012) Identifying the best candidate for radical prostatectomy among patients with high-risk prostate cancer. Eur Urol 61:584–592. doi: 10.1016/j.eururo.2011.11.043

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. miR‑589‑5p is downregulated in prostate cancer and regulates tumor cell viability and metastasis by targeting CCL‑5;Molecular Medicine Reports;2019-06-04